Targeting to BMP9 to restrain flare-up of fibrodysplasia ossificans progressiva
Fibrodysplasia ossificans progressiva (FOP) is a rare genetic disease characterized primarily by the formation of heterotopic bone in connective tissue, such as tendon, muscle, ligament and fascia (Kaplan et al, 2024). The prevalence is approximately one in 2.5 million births, with over 2,500 cases...
Saved in:
Main Authors: | Qiwen Li, Quan Yuan |
---|---|
Format: | Article |
Language: | English |
Published: |
Springer Nature
2024-12-01
|
Series: | EMBO Molecular Medicine |
Online Access: | https://doi.org/10.1038/s44321-024-00180-5 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
BMP-9 mediates fibroproliferation in fibrodysplasia ossificans progressiva through TGF-β signaling
by: Chengzhu Zhao, et al.
Published: (2024-12-01) -
Fibrodysplasia ossificans progressiva: “A skeleton within a skeleton”
by: Kasturi Hazarika, et al.
Published: (2021-01-01) -
Fibrodysplasia Ossificans Progressiva and Pregnancy: A Case Series and Review of the Literature
by: Alexandra D. Forrest, et al.
Published: (2022-01-01) -
Early Detection for Better Patient Outcome: A Case Report on Two Patients Presenting With Fibrodysplasia Ossificans Progressiva at Tikur Anbessa Specialized Hospital, Ethiopia
by: Alazar M. Haile, et al.
Published: (2025-01-01) -
Rapid Progression of Heterotopic Ossification in Severe Variant of Fibrodysplasia Ossificans Progressiva with p.Arg258Gly in ACVR1: A Case Report and Review of Clinical Phenotypes
by: Kosei Hasegawa, et al.
Published: (2022-01-01)